Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 1999 Dec 16;13(4):408–413. doi: 10.1016/0264-410X(95)98265-C

Stimulation of rotavirus IgA, IgG and neutralising antibodies in baboon milk by parenteral vaccination

DR Snodgrass ∗, I Campbell ∗, JM Mwenda †, G Chege †, MA Suleman †, B Morein ‡, CA Hart §
PMCID: PMC7130768  PMID: 7793139

Abstract

A rhesus rotavirus vaccine adjuvanted with ISCOMs was injected intramuscularly to 5 pregnant baboons, with repeated doses 1–2 and 14 weeks after delivery. Maternal blood and milk samples and blood samples from their babies were collected at 2-weekly intervals until 26 weeks after parturition. Samples were assayed for rotavirus antibodies by ELISAs and neutralisation tests. Vaccination produced statistically significant increases in maternal serum IgG and neutralising antibodies, and in milk IgA, IgG, and neutralising antibodies. Control baboon mothers sampled from 12 weeks after delivery had lower serum and milk antibody titres, but responded to vaccination at 16 weeks by producing a similar antibody profile in serum and milk to those previously vaccinated. Because of the endemic nature of human rotaviral infections, similar maternal vaccinations have potential as a means of increasing milk antibodies to a level at which they may be protective to infants.

Keywords: Rotavirus, passive immunisation, maternal vaccination

References

  • 1.Kapikian A.Z., Chanock R.M. Rotaviruses. In: Fields B.N., Knipe D.M., editors. Second Edition. vol. 2. Raven Press; New York: 1990. pp. 1353–1404. (Virology). [Google Scholar]
  • 2.Snodgrass D.R., Browning G.F. Enteric vaccines for farm animals and horses. In: Peters A.R., editor. Vaccines for Veterinary Applications. Butterworth Heinemann; Oxford: 1993. pp. 59–81. [Google Scholar]
  • 3.Kapikian A.Z., Flores J., Vesikari T., Ruuska T., Madore H.P., Green K.Y. Recent advances in development of a rotavirus vaccine for prevention of severe diarrheal illness of infants and young children. In: Mestecky J., Blair C., Ogra P.L., editors. Immunology of Milk and the Neonate. Plenum Press; New York: 1991. [DOI] [PubMed] [Google Scholar]
  • 4.Mebus C.A., White R.G., Bass E.P., Twiehaus M.J. Immunity to neonatal calf diarrhea virus. J. Am. Vet. Med. Ass. 1973;163:880–883. [Google Scholar]
  • 5.Acres S.D., Radostits O.M. The efficacy of a modified live reo-like virus vaccine and an E. coli bacterin for prevention of acute undifferentiated diarrhea of beef calves. Can. Vet. J. 1976;17:197–212. [PMC free article] [PubMed] [Google Scholar]
  • 6.De Leeuw P.W., Ellens D.J., Talmon F.P., Zimmer G.N., Kommeru R. Rotavirus infections in calves: efficacy of oral vaccination in endemically infected herds. Res. Vet. Sci. 1980;29:142–147. doi: 10.1016/S0034-5288(18)32654-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Snodgrass D.R., Fahey K.J., Wells P.W., Campbell I., Whitelaw A. Passive immunity in calf rotavirus infections: maternal vaccination increases and prolongs immunoglobulin G1 antibody secretion in milk. Infect. Immun. 1980;28:344–349. doi: 10.1128/iai.28.2.344-349.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Fahey K.J., Snodgrass D.R., Campbell I., Dawson A.M., Burrells C. IgG1 antibody in milk protects lambs against rotavirus diarrhoea. Vet. Immunol. Immunopathol. 1981;2:27–33. doi: 10.1016/0165-2427(81)90036-2. [DOI] [PubMed] [Google Scholar]
  • 9.Saif L.J., Redman D.R., Smith K.L., Theil K.W. Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from immunised or nonimmunised cows. Infect. Immun. 1983;41:1118–1131. doi: 10.1128/iai.41.3.1118-1131.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Snodgrass D.R. Evaluation of a combined rotavirus and enterotoxigenic Escherichia coli vaccine in cattle. Vet. Rec. 1986;119:39–43. doi: 10.1136/vr.119.2.39. [DOI] [PubMed] [Google Scholar]
  • 11.McNulty M.S., Logan E.F. Effect of vaccination of the dam on rotavirus infection in young calves. Vet. Rec. 1987;120:250–252. doi: 10.1136/vr.120.11.250. [DOI] [PubMed] [Google Scholar]
  • 12.Cornaglia E.M., Fernandez F.M., Gottschalk M., Berrandeguy M.E., Luchelli A., Pasini M.I. Reduction in morbidity due to diarrhea in nursing beef calves by use of an inactivated oil-adjuvanted rotavirus-Escherichia coli vaccine in the dam. Vet. Microbiol. 1992;30:191–202. doi: 10.1016/0378-1135(92)90113-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Castrucci G., Ferrari M., Angelillo V., Rigonat F., Capodicasa L. Field evaluation of the efficacy of Romovac 50, a new inactivated, adjuvanted bovine rotavirus vaccine. Comp. Immunol. Microbiol. Infect. Dis. 1993;16:235–239. doi: 10.1016/0147-9571(93)90150-4. [DOI] [PubMed] [Google Scholar]
  • 14.Welter M.W., Welter C.J. Evaluation of killed and modified live porcine rotavirus vaccines in cesarean derived colostrum deprived pigs. Vet. Microbiol. 1990;22:179–186. doi: 10.1016/0378-1135(90)90105-5. [DOI] [PubMed] [Google Scholar]
  • 15.Hoblet K.H., Saif L.J., Kohler E.M., Theil K.W., Bech-Nielsen S., Stitzlein G.A. Efficacy of an orally administered modified-live porcine-origin rotavirus vaccine against postweaning diarrhea in pigs. Am. J. Vet. Res. 1986;47(8):1697–1703. [PubMed] [Google Scholar]
  • 16.Snodgrass D.R., Fitzgerald T.A., Campbell I., Browning G.F., Scott F.M.M., Hoshino Y., Davies R.C. Homotypic and heterotypic serological responses to rotavirus neutralization epitopes in immunologically naive and experienced animals. J. Clin. Microbiol. 1991;29:2668–2672. doi: 10.1128/jcm.29.11.2668-2672.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Green K.Y., Taniguchi K., Mackow E.R., Kapikian A.Z. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development. J. Infect. Dis. 1990;161:667–679. doi: 10.1093/infdis/161.4.667. [DOI] [PubMed] [Google Scholar]
  • 18.Hoshino Y., Saif L.J., Sereno M.M., Chanock R.M., Kapikian A.Z. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. J. Virol. 1988;62:744–748. doi: 10.1128/jvi.62.3.744-748.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Brussow H., Walther I., Fryder V., Sidoti J., Bruttin A. Cross-neutralizing antibodies induced by single serotype vaccination of cows and rotavirus. J. Gen. Virol. 1988;69:1647–1658. doi: 10.1099/0022-1317-69-7-1647. [DOI] [PubMed] [Google Scholar]
  • 20.Lovgren K., Morein B. The requirement of lipids for the formation of immunostimulating complexes (iscoms) Biotechnol. Appl. Biochem. 1988;10:161–172. [PubMed] [Google Scholar]
  • 21.Saif L.J., Jackwood D.J. Enteric virus vaccines: theoretical considerations, current status, and future approaches. In: Saif L.J., Theil K.W., editors. Viral Diarrheas of Man and Animals. CRC Press; Florida: 1990. pp. 313–329. [Google Scholar]
  • 22.Saif L.J. Passive immunity to coronavirus and rotavirus infections in swine and cattle: enhancement by maternal vaccination. In: Tzipori S., editor. Infectious Diarrhoea in the Young. Elsevier Science Publisher B. V; Amsterdam: 1985. pp. 456–467. [Google Scholar]
  • 23.Newby T.J., Stokes C.R., Bourne F.J. Immunological activities of milk. Vet. Immunol. Immunopathol. 1982:57–94. doi: 10.1016/0165-2427(82)90032-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Goldman A.S., Goldblum R.M. Immunologic system in human milk: characteristics and effects. In: Lebenthal E., editor. Textbook of Gastroenterology and Nutrition in Infancy. Second Edition. Raven Press; New York: 1989. pp. 135–142. [Google Scholar]
  • 25.Goldblum R.M., Ahistedt S., Carisson B., Hanson L.A., Jodal U., Lidinjanson G., Sohl-Akerlund A. Antibody-forming cells in human colostrum after oral immunization. Nature. 1975:257–797. doi: 10.1038/257797a0. [DOI] [PubMed] [Google Scholar]
  • 26.Rahman M.M., Yamauchi M., Hanada N., Nishikawa K., Morishima T. Local production of rotavirus specific IgA in breast tissue and transfer to neonates. Arch. Dis. Child. 1987;62:401–405. doi: 10.1136/adc.62.4.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Svennerholm A.-M., Hanson L.A., Holmgren J., Lindblad B.S., Nilsson B., Quereshi F. Different secretory immunoglobulin A antibody responses to cholera vaccination in Swedish and Pakistani women. Infect. Immun. 1980;30:427–430. doi: 10.1128/iai.30.2.427-430.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Glass R.I., Svennerholm A.-M., Stoll B.J., Khan M.R., Hossain K.M.B., Huq M.I., Holmgren J. Protection against cholera in breast-fed children by antibodies in breast milk. N. Engl. J. Med. 1983;308:1389–1392. doi: 10.1056/NEJM198306093082304. [DOI] [PubMed] [Google Scholar]
  • 29.Bell L.M., Clark H.F., Offit P.A., Slight P.H., Arbeter A.M., Plotkin S.A. Rotavirus serotype-specific neutralizing activity in human milk. AJDC. 1988;142:275–278. [PubMed] [Google Scholar]
  • 30.Cukor G., Blacklow N.R., Capozza F.E., Panjvani Z.F.K., Bednarek F. Persistence of antibodies to rotavirus in human milk. J. Clin. Microbiol. 1979;9:93–96. doi: 10.1128/jcm.9.1.93-96.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ringenbergs M., Albert M.J., Davidson G.P., Goldsworthy W., Haslam R. Serotype-specific antibodies to rotavirus in human colostrum and breast milk and in maternal and cord blood. J. Infect. Dis. 1988;158:477–480. doi: 10.1093/infdis/158.2.477. [DOI] [PubMed] [Google Scholar]
  • 32.McLean B.S., Holmes I.H. Effect of antibodies, trypsin, and trypsin inhibitors on susceptibility of neonates to rotavirus infection. J. Clin. Microbiol. 1981;30:22–29. doi: 10.1128/jcm.13.1.22-29.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Duffy L.C., Byers T.E., Riepenhoff-Talty M., La Scolea L.J., Zielezny M., Ogra P.L. The effects of infant feeding on rotavirus-induced gastroenteritis: a prospective study. Am. J. Publ. Hlth. 1987;76:259–263. doi: 10.2105/ajph.76.3.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Rimer H.C., Wasserman S.S., Flores J., Pichichero M.E., Losonsky G.A. Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversion. J. Infect. Dis. 1992;165:826–830. doi: 10.1093/infdis/165.5.826. [DOI] [PubMed] [Google Scholar]
  • 35.Brussow H., Benitez O., Uribe F., Sidoti J., Rosa K., Cravioto A. Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of life. J. Clin. Microbiol. 1993;31:593–597. doi: 10.1128/jcm.31.3.593-597.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Glass R.I., Stoll B.J., Wyatt R.G., Hoshino Y., Banu H., Kapikian A.Z. Observations questioning a protective role for breast-feeding in severe rotavirus diarrhea. Acta Paediat. Scand. 1986;75:713–718. doi: 10.1111/j.1651-2227.1986.tb10279.x. [DOI] [PubMed] [Google Scholar]
  • 37.Schaller J.P., Saif L.J., Cordle C.T., Candler E., Winship T.R., Smith K.L. Prevention of human rotavirus-induced diarrhea in gnotobiotic piglets using bovine antibody. J. Infect. Dis. 1992;165:623–630. doi: 10.1093/infdis/165.4.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Davidson G.P., Daniels E., Nunan H., Moore A.G., Whyte P.B.D., Franklin K. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. The Lancet. 1989;II:709–712. doi: 10.1016/s0140-6736(89)90771-x. [DOI] [PubMed] [Google Scholar]
  • 39.Ebina T., Ohta M., Kanamaru Y., Yamamoto-Osumi Y., Baba K. Passive immunizations of suckling mice and infants with bovine colostrum containing antibodies to human rotavirus. J. Med. Virol. 1992;38:117–123. doi: 10.1002/jmv.1890380209. [DOI] [PubMed] [Google Scholar]
  • 40.Turner R.B., Kelsey D.K. Passive immunization for prevention of rotavirus illness in healthy infants. Paediat. Infect. Dis. J. 1993;12:718–722. doi: 10.1097/00006454-199309000-00003. [DOI] [PubMed] [Google Scholar]
  • 41.Hoglund S., Dalsgaard K., Lovgren K., Sundquist B., Osterhaus A., Morein B. ISCOMs and immunostimulation with viral antigens. In: Harris J.R., editor. Vol. 15. Plenum Publ; New York: 1989. pp. 39–68. (Subcellular Biochemistry). [DOI] [PubMed] [Google Scholar]
  • 42.Morein B., Akerblom L. The iscom—an approach to subunit vaccines. In: Isaacson R.I., editor. Recombinant DNA Vaccines. Marcel Dekker, Inc; New York: 1992. pp. 369–386. [Google Scholar]
  • 43.Morein B., Ekstrom J., Lovgren K. Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into iscoms. J. Immunol. Meth. 1990;128:177–181. doi: 10.1016/0022-1759(90)90208-d. [DOI] [PubMed] [Google Scholar]
  • 44.Takahashi H., Takeshita T., Morein B., Putney S., Germain R.N., Berzofsky J. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope proteins in iscoms. Nature. 1990;344:873–875. doi: 10.1038/344873a0. [DOI] [PubMed] [Google Scholar]
  • 45.Morein, B., Lovgren, K., Ronnberg, B., Sjolander, A. and Villacres-Eriksson, M. ISCOMs (immune-stimulating complexes): clinical potential in vaccine development. In: Clinical Immunotherapeutics, AIDS International, in press
  • 46.Ronnberg, B., Fekadu, M. and Morein, B. Adjuvant activity of non toxic Quillaja Saponaria Molina components for use in iscom-matrix. Vaccine, in press [DOI] [PubMed]
  • 47.Shaw R.D., Fong K.J., Losonsky G.A., Levine M.M., Macdonado Y., Yolken R., Flores J., Kapikian A.Z., Vo P.T., Greenberg H.B. Epitope-specific immune responses to rotavirus vaccination. Gastroenterology. 1987;93:941–950. doi: 10.1016/0016-5085(87)90555-5. [DOI] [PubMed] [Google Scholar]
  • 48.Bishop R.F., Barnes G.L., Cipriani E., Lund J.S. Clinical immunity after neonatal rotavirus infection. N. Engl. J. Med. 1983;309:72–76. doi: 10.1056/NEJM198307143090203. [DOI] [PubMed] [Google Scholar]

Articles from Vaccine are provided here courtesy of Elsevier

RESOURCES